<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03244579</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT03244579</nct_id>
  </id_info>
  <brief_title>Carbohydrate Counting and DASH Intervention and Pregnancy Outcomes Among Women With Gestational Diabetes</brief_title>
  <official_title>Studying the Effectiveness of Carbohydrate Counting and Dietary Approach to Stop Hypertension Dietary Intervention on Glycemic Control and Maternal and Newborn Health Outcomes Among Jordanian Pregnant Women With Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study is an interventional clinical trial. Pregnant women (aged 25-40 years) diagnosed with&#xD;
      GDM (by a 75-g oral glucose tolerance test at 24-28 weeks' gestation) will be recruited&#xD;
      conveniently from Obstetrics and Gynecology clinic at the Jordan University Hospital and&#xD;
      National Center for Diabetes, Endocrinology and Genetics, Amman, Jordan. A sample of 180&#xD;
      pregnant women with GDM (60 women who do not use insulin and hypoglycemia medications, 60&#xD;
      women who are treated with metformin, 60 women who are treated with insulin), who will meet&#xD;
      the inclusion criteria and will be agreed to participate will be centrally randomized to&#xD;
      follow carbohydrate counting dietary intervention, carbohydrate counting and DASH dietary&#xD;
      intervention, and control dietary intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to compare the effect of carbohydrate counting,&#xD;
      carbohydrate counting and DASH diet dietary interventions and a general dietary intervention&#xD;
      on glycemic control, maternal and neonatal outcomes among Jordanian pregnant women with GDM.&#xD;
      Eligibility criteria to be enrolled in the study will be being Jordanian pregnant women with&#xD;
      GDM at 24 -28 gestational weeks, aged between 25 to 40 with no-personal history of type 1 or&#xD;
      2 diabetes, or impaired fasting glucose, or chronic diseases and singleton gestation. DASH&#xD;
      diet; and the third group will follow the diet prescribed by the hospital for GDM. The&#xD;
      duration of intervention will extend from 24-28 gestational weeks until delivery, which will&#xD;
      be usually 12-14 weeks later. The glycemic controls outcomes are testing fasting blood&#xD;
      glucose, HbA1C, insulin and fructosamine at baseline and at end of intervention for three&#xD;
      dietary interventions. While maternal outcomes are total maternal weight gain (kg), need for&#xD;
      emergency caesarean section, the presence or absence of pregnancy-induced hypertension and&#xD;
      preeclampsia. The new born birth weight, length and head circumference, the presence or&#xD;
      absence of hypoglycemia and shoulder dystocia are the newborn outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">August 20, 2017</start_date>
  <completion_date type="Anticipated">October 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>one year</time_frame>
    <description>Fasting blood glucose in mg/dL at 24 -28 weeks of gestation (baseline) and at 36-37) weeks of gestation(endline) of intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c level</measure>
    <time_frame>one year</time_frame>
    <description>Hemoglobin A1c% at both baseline and endline of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting insulin level</measure>
    <time_frame>one year</time_frame>
    <description>Fasting insulin level in µIU/mL at both baseline and endline of intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fructosamine level</measure>
    <time_frame>one year</time_frame>
    <description>fructosamine in µmol/L at both baseline and endline of intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total maternal weight gain</measure>
    <time_frame>one year</time_frame>
    <description>Total maternal weight gain during pregnancy in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weekly weight gain</measure>
    <time_frame>one year</time_frame>
    <description>weight in kilogram will be measured weekly for all participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin Therapy</measure>
    <time_frame>one year</time_frame>
    <description>Number of participants who need insulin therapy to normalize blood sugar.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency caesarean section</measure>
    <time_frame>one year</time_frame>
    <description>Number of participants who need for emergency caesarean section versus vaginal delivery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy-induced hypertension</measure>
    <time_frame>one year</time_frame>
    <description>Number of participants with existence of hypertension (defined as a blood pressure of at least 140/90 mmHg on two occasions).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn weight</measure>
    <time_frame>one year</time_frame>
    <description>The newborn weight in grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn Length</measure>
    <time_frame>one year</time_frame>
    <description>The new born length in centimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newborn head circumference</measure>
    <time_frame>one year</time_frame>
    <description>The newborn head circumference in centimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemic</measure>
    <time_frame>one year</time_frame>
    <description>Number of newborn babies who will suffer from hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder dystocia</measure>
    <time_frame>one year</time_frame>
    <description>Number of newborn babies with shoulder dystocia.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Gestational Diabetes Mellitus With Baby Delivered</condition>
  <arm_group>
    <arm_group_label>Dietary intervention CHO counting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbohydrate counting diet will be prepared according to Kulkarni, (2005). Tailored diet plans according to patient's food preference, physical activity level and appropriate insulin: Carbohydrates ratio will be prescribed for each participants. Diets were based on each participants's recommended intakes of energy, protein (15-25%), fat (30-40%) and carbohydrate (40-50%) (Thomas and Gutierrez, 2005; Kleinwechter et al., 2014). Energy requirement will be determined in the participants' pre-pregnancy weight with adding the extra requirement (450 kcal) due to pregnancy. The carbohydrate counts will be distributed into three main meals and 3 snacks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary intervention CHO Counting &amp; DASH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The recommended intakes of energy, protein (15-25%), fat (30-40%) and carbohydrate (40-50%) will be similar to that in carbohydrate counting diet which mentioned above. DASH diet food choices will be inserted in the diet of the participants assigned for the combined diet of DASH and carbohydrate counting. The emphasis will be more on the fruits and vegetables group (&gt;8 servings/day), whole grains (at least half of the amount of the total servings of cereals; 6-8 servings/day), fat free dairy products (2-3 servings/day), lean meat and plant proteins (0-2 servings/day) and nuts (5-7 servings/week). From the fat group olive oil will represent the main type of fat (20-25% of total fat %). Adequate intake of sodium (2000mg) will be applied into participants' diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Dietary guidlines</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the general dietary advice and diet that will be prescribed by hospital for participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Adjusting the quantity and quality of food intake to improve glycemic control, maternal and newborn health outcomes of women with gestational diabetes.</description>
    <arm_group_label>Dietary intervention CHO Counting &amp; DASH</arm_group_label>
    <arm_group_label>Dietary intervention CHO counting</arm_group_label>
    <other_name>diet therpy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Jordanian pregnant women with GDM at 24 -28 gestational weeks.&#xD;
&#xD;
          -  Aged 25-40 with no-personal history of type 1 or 2 diabetes, or impaired fasting&#xD;
             glucose (Koivusalo et al., 2016).&#xD;
&#xD;
          -  Singleton gestation (Louie et al., 2011).&#xD;
&#xD;
          -  Absence of chronic diseases such as hypertension, hepatic and kidney disease and&#xD;
             cancer, and psychiatric disorder (Ma et al., 2014).&#xD;
&#xD;
          -  Absence of the use of medication that influences glucose metabolism, such as&#xD;
             continuous therapy with oral corticosteroids (Koivusalo et al., 2016)&#xD;
&#xD;
          -  Pregnant women who do not have special dietary requirements (Louie et al., 2011).&#xD;
&#xD;
        Nonsmoker or nonalcoholic drinker during pregnancy (Louie et al., 2011) Well educated and&#xD;
        well cooperative, more than 10 years of formal schooling (Ma et al., 2014).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non- Jordanian pregnant women or Jordanian pregnant women with GDM at &lt;24 or &gt;28&#xD;
             gestational weeks.&#xD;
&#xD;
          -  Aged &gt; 40 years with multiple gestation and suspected over-diabetes (Koivusalo et al.,&#xD;
             2016).&#xD;
&#xD;
          -  Multiple gestations (Louie et al., 2011).&#xD;
&#xD;
          -  Presence of chronic diseases, severe psychiatric disorder. Women with the risk factors&#xD;
             for placental insufficiency, or history of preeclampsia (Ma et al., 2014; Koivusalo et&#xD;
             al., 2016).&#xD;
&#xD;
          -  Presence of the use of medication that influences glucose metabolism, such as&#xD;
             continuous therapy with oral corticosteroids (Koivusalo et al., 2016)&#xD;
&#xD;
          -  Pregnant women who have special dietary requirements (Louie et al., 2011).&#xD;
&#xD;
          -  Who smoked or consumed alcohol during pregnancy (Louie et al., 2011)&#xD;
&#xD;
          -  Less than 10 years of formal schooling or previous intensive nutrition education or&#xD;
             intervention for diabetes (Ma et al., 2014).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reema F Tayyem, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Jordan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabika S Allehdan, Msc</last_name>
    <phone>+962799232789</phone>
    <email>sabika_1986@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reema F Tayyem, PhD</last_name>
    <phone>+962797902535</phone>
    <email>r_tayyem@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sabika Allehdan</name>
      <address>
        <city>Amman</city>
        <zip>009626</zip>
        <country>Jordan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabika Allehdan, MSc</last_name>
      <phone>799232789</phone>
      <email>sabika_1986@Yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <reference>
    <citation>Kulkarni DK. Carbohydrate counting: A practical meal-planning option for people with diabetes. Clinical Diabetes 23:120-22, 2005.</citation>
  </reference>
  <reference>
    <citation>Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, Kaaja RJ, Poyhonen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinila J, Kautiainen H, Eriksson JG, Stach-Lempinen B. Erratum. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). A Randomized Controlled Trial. Diabetes Care 2016;39:24-30. Diabetes Care. 2017 Aug;40(8):1133. doi: 10.2337/dc17-er08a. Epub 2017 Jun 14. No abstract available.</citation>
    <PMID>28615238</PMID>
  </reference>
  <reference>
    <citation>Ma WJ, Huang ZH, Huang BX, Qi BH, Zhang YJ, Xiao BX, Li YH, Chen L, Zhu HL. Intensive low-glycaemic-load dietary intervention for the management of glycaemia and serum lipids among women with gestational diabetes: a randomized control trial. Public Health Nutr. 2015 Jun;18(8):1506-13. doi: 10.1017/S1368980014001992. Epub 2014 Sep 15.</citation>
    <PMID>25222105</PMID>
  </reference>
  <reference>
    <citation>Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, Brand-Miller JC. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care. 2011 Nov;34(11):2341-6. doi: 10.2337/dc11-0985. Epub 2011 Sep 6.</citation>
    <PMID>21900148</PMID>
  </reference>
  <reference>
    <citation>Thomas, A. M. and Gutierrez, Y.M. (2005), American Dietetic Association guide to gestational diabetes mellitus. Chicago, IL: American Dietetic Association. Received from http://www.eatright.org/Public/ProductCatalog/ SearchableProducts/104_20728.cfm. Accessed 23 January 2016.</citation>
  </reference>
  <reference>
    <citation>Kleinwechter H, Schafer-Graf U, Buhrer C, Hoesli I, Kainer F, Kautzky-Willer A, Pawlowski B, Schunck K, Somville T, Sorger M; German Diabetes Association; German Association for Gynaecology and Obstetrics. Gestational diabetes mellitus (GDM) diagnosis, therapy and follow-up care: Practice Guideline of the German Diabetes Association(DDG) and the German Association for Gynaecologyand Obstetrics (DGGG). Exp Clin Endocrinol Diabetes. 2014 Jul;122(7):395-405. doi: 10.1055/s-0034-1366412. Epub 2014 Jul 11. No abstract available.</citation>
    <PMID>25014091</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 31, 2017</study_first_submitted>
  <study_first_submitted_qc>August 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2017</study_first_posted>
  <last_update_submitted>November 21, 2018</last_update_submitted>
  <last_update_submitted_qc>November 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>Sabika Salem Allehdan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03244579
org study id: 2
nct id: NCT03244579
lead sponsor: 
has dmc: Yes
is fda regulated drug: No
is fda regulated device: No
Study is an interventional clinical trial. Pregnant women (aged 25-40 years) diagnosed with
      GDM (by a 75-g oral glucose tolerance test at 24-28 weeks' gestation) will be recruited
      conveniently from Obstetrics and Gynecology clinic at the Jordan University Hospital and
      National Center for Diabetes, Endocrinology and Genetics, Amman, Jordan. A sample of 180
      pregnant women with GDM (60 women who do not use insulin and hypoglycemia medications, 60
      women who are treated with metformin, 60 women who are treated with insulin), who will meet
      the inclusion criteria and will be agreed to participate will be centrally randomized to
      follow carbohydrate counting dietary intervention, carbohydrate counting and DASH dietary
      intervention, and control dietary intervention.
The main objective of this study is to compare the effect of carbohydrate counting,
      carbohydrate counting and DASH diet dietary interventions and a general dietary intervention
      on glycemic control, maternal and neonatal outcomes among Jordanian pregnant women with GDM.
      Eligibility criteria to be enrolled in the study will be being Jordanian pregnant women with
      GDM at 24 -28 gestational weeks, aged between 25 to 40 with no-personal history of type 1 or
      2 diabetes, or impaired fasting glucose, or chronic diseases and singleton gestation. DASH
      diet; and the third group will follow the diet prescribed by the hospital for GDM. The
      duration of intervention will extend from 24-28 gestational weeks until delivery, which will
      be usually 12-14 weeks later. The glycemic controls outcomes are testing fasting blood
      glucose, HbA1C, insulin and fructosamine at baseline and at end of intervention for three
      dietary interventions. While maternal outcomes are total maternal weight gain (kg), need for
      emergency caesarean section, the presence or absence of pregnancy-induced hypertension and
      preeclampsia. The new born birth weight, length and head circumference, the presence or
      absence of hypoglycemia and shoulder dystocia are the newborn outcomes.
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Treatment
masking: Single (Outcomes Assessor)
measure: Fasting blood glucose
time frame: one year
description: Fasting blood glucose in mg/dL at 24 -28 weeks of gestation (baseline) and at 36-37) weeks of gestation(endline) of intervention.
measure: Hemoglobin A1c level
time frame: one year
description: Hemoglobin A1c% at both baseline and endline of intervention
measure: Fasting insulin level
time frame: one year
description: Fasting insulin level in µIU/mL at both baseline and endline of intervention.
measure: Fructosamine level
time frame: one year
description: fructosamine in µmol/L at both baseline and endline of intervention.
measure: Total maternal weight gain
time frame: one year
description: Total maternal weight gain during pregnancy in kilograms
measure: Weekly weight gain
time frame: one year
description: weight in kilogram will be measured weekly for all participants
measure: Insulin Therapy
time frame: one year
description: Number of participants who need insulin therapy to normalize blood sugar.
measure: Emergency caesarean section
time frame: one year
description: Number of participants who need for emergency caesarean section versus vaginal delivery.
measure: Pregnancy-induced hypertension
time frame: one year
description: Number of participants with existence of hypertension (defined as a blood pressure of at least 140/90 mmHg on two occasions).
measure: Newborn weight
time frame: one year
description: The newborn weight in grams
measure: Newborn Length
time frame: one year
description: The new born length in centimeters.
measure: Newborn head circumference
time frame: one year
description: The newborn head circumference in centimeters.
measure: Hypoglycemic
time frame: one year
description: Number of newborn babies who will suffer from hypoglycemia
measure: Shoulder dystocia
time frame: one year
description: Number of newborn babies with shoulder dystocia.
arm group label: Dietary intervention CHO counting
arm group type: Experimental
description: Carbohydrate counting diet will be prepared according to Kulkarni, (2005). Tailored diet plans according to patient's food preference, physical activity level and appropriate insulin: Carbohydrates ratio will be prescribed for each participants. Diets were based on each participants's recommended intakes of energy, protein (15-25%), fat (30-40%) and carbohydrate (40-50%) (Thomas and Gutierrez, 2005; Kleinwechter et al., 2014). Energy requirement will be determined in the participants' pre-pregnancy weight with adding the extra requirement (450 kcal) due to pregnancy. The carbohydrate counts will be distributed into three main meals and 3 snacks.
arm group label: Dietary intervention CHO Counting & DASH
arm group type: Experimental
description: The recommended intakes of energy, protein (15-25%), fat (30-40%) and carbohydrate (40-50%) will be similar to that in carbohydrate counting diet which mentioned above. DASH diet food choices will be inserted in the diet of the participants assigned for the combined diet of DASH and carbohydrate counting. The emphasis will be more on the fruits and vegetables group (>8 servings/day), whole grains (at least half of the amount of the total servings of cereals; 6-8 servings/day), fat free dairy products (2-3 servings/day), lean meat and plant proteins (0-2 servings/day) and nuts (5-7 servings/week). From the fat group olive oil will represent the main type of fat (20-25% of total fat %). Adequate intake of sodium (2000mg) will be applied into participants' diet.
arm group label: General Dietary guidlines
arm group type: No Intervention
description: the general dietary advice and diet that will be prescribed by hospital for participants
intervention type: Behavioral
intervention name: Dietary Intervention
description: Adjusting the quantity and quality of food intake to improve glycemic control, maternal and newborn health outcomes of women with gestational diabetes.
arm group label: Dietary intervention CHO Counting & DASH
arm group label: Dietary intervention CHO counting
other name: diet therpy
criteria: 
gender: Female
minimum age: 25 Years
maximum age: 40 Years
healthy volunteers: No
last name: Reema F Tayyem, PhD
role: Study Director
affiliation: University of Jordan
last name: Sabika S Allehdan, Msc
phone: +962799232789
email: sabika_1986@yahoo.com
last name: Reema F Tayyem, PhD
phone: +962797902535
email: r_tayyem@yahoo.com
facility: 
status: Recruiting
contact: 
country: Jordan
citation: Kulkarni DK. Carbohydrate counting: A practical meal-planning option for people with diabetes. Clinical Diabetes 23:120-22, 2005.
citation: Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, Kaaja RJ, Poyhonen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinila J, Kautiainen H, Eriksson JG, Stach-Lempinen B. Erratum. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). A Randomized Controlled Trial. Diabetes Care 2016;39:24-30. Diabetes Care. 2017 Aug;40(8):1133. doi: 10.2337/dc17-er08a. Epub 2017 Jun 14. No abstract available.
PMID: 28615238
citation: Ma WJ, Huang ZH, Huang BX, Qi BH, Zhang YJ, Xiao BX, Li YH, Chen L, Zhu HL. Intensive low-glycaemic-load dietary intervention for the management of glycaemia and serum lipids among women with gestational diabetes: a randomized control trial. Public Health Nutr. 2015 Jun;18(8):1506-13. doi: 10.1017/S1368980014001992. Epub 2014 Sep 15.
PMID: 25222105
citation: Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, Brand-Miller JC. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care. 2011 Nov;34(11):2341-6. doi: 10.2337/dc11-0985. Epub 2011 Sep 6.
PMID: 21900148
citation: Thomas, A. M. and Gutierrez, Y.M. (2005), American Dietetic Association guide to gestational diabetes mellitus. Chicago, IL: American Dietetic Association. Received from http://www.eatright.org/Public/ProductCatalog/ SearchableProducts/104_20728.cfm. Accessed 23 January 2016.
citation: Kleinwechter H, Schafer-Graf U, Buhrer C, Hoesli I, Kainer F, Kautzky-Willer A, Pawlowski B, Schunck K, Somville T, Sorger M; German Diabetes Association; German Association for Gynaecology and Obstetrics. Gestational diabetes mellitus (GDM) diagnosis, therapy and follow-up care: Practice Guideline of the German Diabetes Association(DDG) and the German Association for Gynaecologyand Obstetrics (DGGG). Exp Clin Endocrinol Diabetes. 2014 Jul;122(7):395-405. doi: 10.1055/s-0034-1366412. Epub 2014 Jul 11. No abstract available.
PMID: 25014091
responsible party type: Principal Investigator
investigator affiliation: University of Jordan
investigator full name: Sabika Salem Allehdan
investigator title: Principal Investigator
mesh term: Diabetes, Gestational
mesh term: Diabetes Mellitus
sharing ipd: Undecided